GLP-1s · Peptides · Longevity
GLP-1 medications,
without the hype.
Independent research on what the evidence shows, what the programs really cost, and how to qualify — the leading GLP-1s compared side by side, plus the wider peptide world they opened up.
Independent · No paid placement · Updated 2026
Online GLP-1 programs
Full comparison →Online semaglutide and tirzepatide programs, compared on price, medications, and support. Pricing is approximate; verify on each provider's site. Not sure which fits? Take the 30-second finder →
| Provider | Starting Price | Medications | Support | ||
|---|---|---|---|---|---|
| 01 | EmbodyTop Pick | ~$149/mo | semaglutide, tirzepatide | Licensed providers, medically guided GLP-1 plans, home delivery | Check eligibility → |
| 02 | Sprout Health | ~$249/mo | semaglutide, tirzepatide | Streamlined telehealth, physician oversight | View |
| 03 | System Labs | Check current pricing | semaglutide, tirzepatide | Licensed clinicians, lab-tested peptides, certified pharmacies, direct delivery | View |
| 04 | SHED | Check current pricing | semaglutide | Health coaching, supplements, nationwide membership | View |
| 05 | SkinnyRx | ~$199/mo | semaglutide, tirzepatide | Telehealth, financing support | View |
| 06 | Yucca Health | from ~$146/moLowest listed | semaglutide, tirzepatide | Telehealth, 2-day pharmacy fulfillment, all 50 states | View |
- Price
- ~$149/mo
- Medications
- semaglutide, tirzepatide
- Support
- Licensed providers, medically guided GLP-1 plans, home delivery
- Price
- ~$249/mo
- Medications
- semaglutide, tirzepatide
- Support
- Streamlined telehealth, physician oversight
- Price
- Check current pricing
- Medications
- semaglutide, tirzepatide
- Support
- Licensed clinicians, lab-tested peptides, certified pharmacies, direct delivery
- Price
- Check current pricing
- Medications
- semaglutide
- Support
- Health coaching, supplements, nationwide membership
- Price
- ~$199/mo
- Medications
- semaglutide, tirzepatide
- Support
- Telehealth, financing support
- Price
- from ~$146/moLowest listed
- Medications
- semaglutide, tirzepatide
- Support
- Telehealth, 2-day pharmacy fulfillment, all 50 states
The Compound is an independent research site covering GLP-1 medications and the broader peptide category — semaglutide, tirzepatide, retatrutide, and longevity compounds like GHK-Cu and thymosin alpha-1. It answers what the clinical evidence shows, what treatment actually costs, and how to access these compounds through legitimate channels. The Compound does not prescribe, dispense, or sell medications.
Recovery & Longevity
Metabolic peptides are just the entry point
GHK-Cu, thymosin alpha-1, Ipamorelin — the compounds the longevity world has been using for years are finally getting mainstream attention. The stack behind the stack matters.
Latest news
All news →FDA decisions, trial results, and pipeline moves — with what the data actually shows.
GLP-1 Drugs and Cancer Risk
A 160,000-patient 2026 study found GLP-1 use linked to a 41% lower risk of obesity-associated cancers.
Aug 12, 2026Foundayo Wins UK Approval
The MHRA approved Foundayo (orforglipron) on August 10, 2026, the first European authorization for the drug. Not yet on the NHS, and nothing changes for US patients already on it.
Aug 11, 2026Is Retatrutide a Biologic? The FDA Lawsuit
A federal judge vacated the FDA's classification of retatrutide as a drug in September 2025. Lilly has appealed, and oral arguments land September 24, 2026, with 7 years of exclusivity and future compounding rights on the line.
Aug 10, 2026Is Compounded Semaglutide Legal in 2026?
503B bulk compounding of semaglutide ended February 21, 2025. The FDA proposed a permanent exclusion April 30, 2026, but no final rule has published since the comment period closed June 29.
